Rossari Biotech Limited (ROSSARI) - Total Liabilities

Latest as of September 2025: Rs8.36 Billion INR ≈ $90.46 Million USD

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has total liabilities worth Rs8.36 Billion INR (≈ $90.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Rossari Biotech Limited (ROSSARI) cash flow conversion to assess how effectively this company generates cash.

Rossari Biotech Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. Check Rossari Biotech Limited (ROSSARI) asset resilience to evaluate the company's liquid asset resilience ratio.

Rossari Biotech Limited Competitors by Total Liabilities

The table below lists competitors of Rossari Biotech Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Citizens Financial Services Inc. Common Stock NASDAQ:CZFS	USA	$2.73 Billion
Microbio Co Ltd TWO:4128	Taiwan	NT$2.04 Billion
NACCO Industries Inc NYSE:NC	USA	$231.99 Million
Norwood Financial Corp NASDAQ:NWFL	USA	$2.18 Billion
Western New England Bancorp Inc NASDAQ:WNEB	USA	$2.49 Billion
Transcontinental Inc TO:TCL-A	Canada	CA$1.37 Billion
Incap Oyj HE:ICP1V	Finland	€68.95 Million
CompX International Inc NYSE MKT:CIX	USA	$17.56 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Rossari Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Rossari Biotech Limited.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.67	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rossari Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rossari Biotech Limited (2017–2025)

The table below shows the annual total liabilities of Rossari Biotech Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs7.11 Billion ≈ $76.86 Million	+35.53%
2024-03-31	Rs5.24 Billion ≈ $56.71 Million	+15.92%
2023-03-31	Rs4.52 Billion ≈ $48.93 Million	+0.19%
2022-03-31	Rs4.52 Billion ≈ $48.83 Million	+195.96%
2021-03-31	Rs1.53 Billion ≈ $16.50 Million	-17.45%
2020-03-31	Rs1.85 Billion ≈ $19.99 Million	+46.66%
2019-03-31	Rs1.26 Billion ≈ $13.63 Million	+61.85%
2018-03-31	Rs778.70 Million ≈ $8.42 Million	+13.00%
2017-03-31	Rs689.09 Million ≈ $7.45 Million	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$286.86 Million

Rs26.52 Billion INR

Market Cap Rank

#15144 Global

#743 in India

Share Price

Rs478.95

Change (1 day)

+2.56%

52-Week Range

Rs378.60 - Rs743.30

All Time High

Rs1568.62